For the first time, researchers have identified a protein that represses the activity of energy-burning brown fat. The ...

Obesity, diabetes and cardiovascular diseases are increasingly present in the population. Brown adipose tissue has a ...

Scientists have unlocked new details on important receptor proteins—promising targets for the creation of novel drugs for ...

Obesity, diabetes and cardiovascular diseases are increasingly present in the population. Brown adipose tissue has a ...

Phase 2a data on Skye Bioscience's (NASDAQ:SKYE) cannabinoid-1 receptor blocker (CB1) for obesity, nimacimab, should be ...

Low-dose colchicine therapy may not alter pericoronary adipose tissue attenuation but can help in improving plaque stability ...

Measuring coronary inflammation with CT imaging improves long-term risk assessment following percutaneous coronary ...

The trial will initially involve healthy obese people receiving single and multiple escalating doses of the therapy.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-ALK7, the company’s investigational RNA interference (RNAi) ...

Associations of road traffic noise with adipose tissue depots and hepatic health – Results from the NAKO study. 2025 Environment International. Volume 201 ...